Paving the way for patient centricity in real-world evidence (RWE): Qualitative interviews to identify considerations for wider implementation of patient-reported outcomes in RWE generation

被引:3
|
作者
Maruszczyk, Konrad [1 ,2 ]
McMullan, Christel [1 ,2 ,3 ]
Aiyegbusi, Olalekan Lee [1 ,2 ,4 ,8 ]
Keeley, Thomas [1 ,2 ,5 ]
Wilson, Roger [1 ,2 ]
Collis, Philip [1 ,2 ]
Bottomley, Catherine [6 ]
Calvert, Melanie J. [1 ,2 ,7 ]
机构
[1] Univ Birmingham, Ctr Patient Reported Outcome Res, Birmingham, England
[2] Univ Birmingham, Birmingham Hlth Partners Ctr Regulatory Sci & Inno, Birmingham, England
[3] Univ Birmingham, NIHR Blood & Transplant Res Unit BTRU Precis Trans, Birmingham, England
[4] Univ Birmingham, NIHR Appl Res Collaborat ARC West Midlands, Birmingham, England
[5] GlaxoSmithKline GSK, Patient Ctr Outcomes Value Evidence & Outcomes, Brentford, England
[6] Vitaccess Ltd, Oxford, England
[7] Univ Birmingham, NIHR Birmingham Biomed Res Ctr, Birmingham, England
[8] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcome Res, Murray Learning Ctr Edgbaston, Birmingham B15 2TT, England
关键词
CANCER CARE; INCLUSION; TRIALS;
D O I
10.1016/j.heliyon.2023.e20157
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Real-world evidence (RWE) generation can be enhanced by including patient-reported outcomes (PROs). Methods for collecting and using PRO data in the real-world setting are currently underdeveloped and there is no international guidance specific to its use in this context. This study explored stakeholders' perspectives and needs for using PROs in RWE generation. Barriers, facilitators, and opportunities for wider use of PROs in real-world studies were also investigated.Methods: Online semi-structured interviews were conducted with international stakeholders: patients, patient advocates, regulators, payers, clini-cians, academic researchers, and industry experts. Interviews were recorded, transcribed verbatim and analysed using NVivo 20. Thematic analysis was conducted based on the updated Consolidated Framework for Implementation Research (CFIR). Results: Twenty-three interviews were conducted. Participants confirmed that the use of PROs in RWE generation is not yet well established. Participants expressed a mixed level of confidence in the value of PROs collected in a real-world setting. Operational challenges associated with collecting routine PRO data to inform care delivery at the individual level (e.g., setting up infrastructure) need to be addressed. Methodological and other challenges (e.g., financing research) associated with collecting prospective de novo data in a real-world setting should be considered to facilitate PRO utilisation in real-world studies.Conclusions: Several opportunities and challenges were identified regarding the broader use of PROs in RWE research. Joint efforts from different stakeholders are needed to maximise PRO implementation, with consideration given to each stakeholders' specific needs (e.g., by developing good practices).
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Exploring the implementation of patient-reported outcome measures in cancer care: Need for more real-world evidence results in the peer reviewed literature
    Anatchkova M.
    Donelson S.M.
    Skalicky A.M.
    McHorney C.A.
    Jagun D.
    Whiteley J.
    [J]. Journal of Patient-Reported Outcomes, 2 (1)
  • [42] Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021)
    Maruszczyk, Konrad
    Aiyegbusi, Olalekan Lee
    Cardoso, Victor Roth
    Gkoutos, Georgios V.
    Slater, Karin
    Collis, Philip
    Keeley, Thomas
    Calvert, Melanie J.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2022, 120
  • [43] Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021)
    Maruszczyk, Konrad
    Aiyegbusi, Olalekan Lee
    Cardoso, Victor Roth
    Gkoutos, Georgios V.
    Slater, Luke T.
    Collis, Philip
    Keeley, Thomas
    Calvert, Melanie J.
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 : S116 - S116
  • [44] REAL-WORLD SEVERE SYMPTOM TRAJECTORY IN MULTIPLE MYELOMA REPORTED IN REMOTE SYMPTOM MONITORING WITH ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO)
    Rusli, E.
    Galaznik, A.
    Coombs, N. C.
    Beamon, E.
    Wildes, T. M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S353 - S353
  • [45] A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe
    Janet H. Ford
    Shonda A. Foster
    Russell M. Nichols
    Antje Tockhorn-Heidenreich
    Wenyu Ye
    James Jackson
    Sarah Cotton
    [J]. Journal of Patient-Reported Outcomes, 4
  • [46] Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura K.
    Duffin, Kristina Callis
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [47] Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient-Reported Outcomes and Treatment: Analysis of Real-World Data
    Touma, Zahi
    Hoskin, Ben
    Atkinson, Christian
    Bell, David
    Massey, Olivia
    Lofland, Jennifer H.
    Berry, Pamela
    Karyekar, Chetan S.
    Costenbader, Karen H.
    [J]. ARTHRITIS CARE & RESEARCH, 2022, 74 (07) : 1079 - 1088
  • [48] Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings
    Walker, Mark S.
    Wong, William
    Ravelo, Arliene
    Miller, Paul J. E.
    Schwartzberg, Lee S.
    [J]. CLINICAL LUNG CANCER, 2018, 19 (02) : 139 - 147
  • [49] Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia By Cytogenetic Risk and Treatment Status
    Jamy, Omer H.
    Coombs, Nicholas
    Wujcik, Debra M.
    Galaznik, Aaron
    [J]. BLOOD, 2022, 140 : 7959 - 7960
  • [50] Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study
    Wilmot, Emma G.
    Close, Kelly L.
    Jurisic-Erzen, Dubravka
    Bruttomesso, Daniela
    Ampudia-Blasco, F. Javier
    Bosnyak, Zsolt
    Roborel de Climens, Aude
    Bigot, Gregory
    Peters, Anne L.
    Renard, Eric
    Berard, Lori
    Calliari, Luis Eduardo
    Seufert, Jochen
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1892 - 1901